Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.

Ali Kabir Ahmad Sofi-Mahmudi Arman Karimi Behnagh Vahid Eidkhani Hamid Reza Baradaran Payam Kabiri Ali Akbar Haghdoost Bita Mesgarpour

Published in: Archives of Iranian medicine (2022)

The RoB in Iranian RCTs was found to be mostly high or unclear. While this is similar to the global situation, it is recommended that the methodological quality of conducting and reporting RCTs be addressed in Iran.

Keyphrases

adverse drug
quality improvement
randomized controlled trial
emergency department
drug induced